Basel Medical BMGL Income Statement (2023-2025)

NASDAQ BMGL
$4.68 -0.26 (-5.26%)
At close: Sep 3, 2026 · 4:00 PM EDT
Reported Financials

Basel Medical Quarterly Income Statement

Periods 5 quarters
Latest Dec 2025

Basel Medical income statement data for the quarter ended Dec 2025. This income statement covers 5 quarters of results from Dec 2023 through Dec 2025, standardized by Business Quant from the company’s SEC filings.

1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2023 Jun2024 Dec2024 Jun2025 Dec2025
Revenue & cost
Revenue 5.09M0.34M
Operating items
Depreciation & Amortization - TotalDep. & Amort. (Tot) -0.27M-0.35M0.11M-2.06M
Other Operating ExpensesOther Opex -0.35M
Operating ExpensesOpex -0.27M-0.47M0.11M-2.06M
EBIT 1.84M0.22M
Non-operating items
Non Operating Interest Expenses -0.10M-0.10M0.85M-0.22M
Other Non Operating IncomeOther Non Op Inc. -0.01M
Net income details
EBT 1.94M0.32M
Tax ProvisionsTaxes -0.61M-388.00-0.18M
Profit After TaxPAT 1.33M0.32M
Income from Non-Controlling InterestsInc. Minority 0.00M0.12M
Income from Continuing OperationsIncome (Continuing) 2.55M0.32M
Consolidated Net IncomeConsol Net Inc. 2.55M0.32M
Income towards Parent CompanyParent Net Inc 2.55M0.32M
Net Income towards Common StockholdersNet Income 2.55M-0.33M0.69M
Additional items
EPS (Basic) -0.240.44
EPS (Diluted) -0.240.44
Shares Outstanding 1.35M1.35M1.57M1.57M
Shares Outstanding (Diluted)Shares Outstanding (Dil.) 1.35M1.35M1.57M1.57M
Shares Outstanding (Entity)Shares Outstanding (Entity.) 1.35M1.57M
EBITDA 1.58M-0.13M
Interest ExpensesInt Expense -0.10M-0.10M0.85M-0.22M
Tax Rate -31.55%-0.12%